不同肾小球疾病的心血管风险差异
基于中国肾脏数据系统2000至2022年66,247例14种病因肾小球疾病患者,比较心血管死亡风险。IgA肾病最常见(39%),其次狼疮性肾炎(17%)和膜性肾病(16%)。所有肾小球疾病患者心血管死亡风险均高于一般人群,狼疮性肾炎风险最高(间接标化死亡比27.9),微小病变最低(3.91)。
要点
- 不同病因肾小球疾病患者心血管死亡风险存在显著异质性。
- 狼疮性肾炎心血管死亡风险最高(间接标化死亡比27.9)。
- 所有肾小球疾病亚型心血管死亡风险均高于一般人群。
核心结论
- 不同基础肾小球疾病患者的心血管风险谱存在显著异质性且均升高。
研究设计与样本
- 基于中国肾脏数据系统的队列研究,纳入2000至2022年66,247例14种病因肾小球疾病患者。
- 比较不同病因患者的心血管死亡、缺血性心脏病相关死亡和卒中相关死亡风险。
主要发现
- IgA肾病最常见(39%),其次为狼疮性肾炎(17%)和膜性肾病(16%)。
- 随访期间记录心血管死亡971例(1%)、缺血性心脏病相关死亡337例(0.5%)、卒中相关死亡286例(0.4%)。
- 各亚型粗心血管死亡率范围为0.7至22.6/1000人年。
- 所有肾小球疾病患者心血管死亡风险均高于一般人群,狼疮肾炎间接标化死亡比最高(27.9),微小病变最低(3.91)。
- 与微小病变患者直接比较,其他所有肾小球疾病亚型心血管死亡风险均显著更高。
临床怎么用
- 对肾小球疾病患者应早期发现和准确评估心血管受累情况。
- 不同病因的肾小球疾病患者心血管风险不同,需个体化评估与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: The incidence rate of cardiovascular death in the overall GN cohort varied by primary cause. Compared with the general population, patients with various subtypes of GN exhibited higher cardiovascular death risks. Early detection and accurate assessment of cardiovascular involvement in the GN population with different etiologies were essential. BACKGROUND: It was well-established that patients with GN face an elevated cardiovascular risk, yet little was known about the differential impacts of various etiologies of glomerular disease on cardiovascular outcomes. In this large cohort study encompassing patients with distinct forms of GN, we aimed to compare the effects of different etiologies on cardiovascular death events. METHODS: Using data from the China Renal Data System database, we identified 66,247 patients with GN across 14 distinct etiologies between 2000 and 2022. The risks of cardiovascular death, ischemic heart disease-associated death, and stroke-associated death among different types of patients were compared. RESULTS: Within a cohort of 66,247 patients with GN, IgA nephropathy (39%) was the most prevalent etiology, followed by lupus nephritis (17%) and membranous nephropathy (16%). During follow-up, 971 cardiovascular deaths (1%), 337 ischemic heart-associated deaths (0.5%), and 286 stroke-associated deaths (0.4%) were recorded. The overall crude cardiovascular death rates across GN subtypes ranged from 0.7 to 22.6 per 1000 person-years. All patients with glomerular diseases demonstrated elevated cardiovascular death risks compared with the general population, with lupus nephritis exhibiting the highest risk (indirect standardized mortality ratio of 27.9) and minimal change disease the lowest (indirect standardized mortality ratio of 3.91). Furthermore, when compared directly with patients with minimal change disease, all other GN subtypes were associated with significantly greater cardiovascular death risk. CONCLUSIONS: Patients with different underlying glomerular diseases exhibited markedly heterogeneous and elevated cardiovascular risk profiles.
引用
- Jin L, Liu J, She C, et al. Cardiovascular Risk across Different Glomerular Diseases. J Am Soc Nephrol. 2026. PMID: 42485662. doi:10.1681/ASN.0000001165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。